Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Community volunteer-based early malaria diagnosis and treatment in rural Myanmar
ACTRN12610000706077Phase 4Recruiting
- Sponsor
- World Health Organization Regional Office for the South-East Asia - UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) Small Grants Programme (WHO/SEARO-TDR Small Grants Programme)
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lumefantrine and chloroquine in malaria and Malaria (2 arms), sponsored by World Health Organization Regional Office for the South-East Asia - UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) Small Grants Programme (WHO/SEARO-TDR Small Grants Programme). Primary endpoints: Interval between first febrile episode and diagnosis by rapid diagnostic test, Proportion receiving malaria diagnosis and appropriate treatment and 1 more. Started May 2009; status: recruiting.
02
Drugs
lumefantrinechloroquine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12610000706077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000706077.